Newsletter

000250 - Samchundang Pharm

000250 Summary
Biopharma
Stock Price & Overview
₩157,000 +1,600 (+1.03%) Close · Sep 4, 2026 KST
KOSDAQ | ₩KRW | Close: ₩157,000  ≈ US$112  ·  Market cap ₩3.7tn (≈ $2.6bn)
Home › 000250 › Filings

Half-Year Report

DART
Samchundang Pharm
Filed Aug 14, 2026 KST · Periodic · receipt 20260814003598

kstock has not written this one up. The title above is a translation of the Korean form name; the filing itself is on DART, in Korean.

Read the original on DART ↗ Korean. DART is Korea's electronic disclosure system, run by the Financial Supervisory Service — the filing equivalent of EDGAR.
Korean form name: 반기보고서 (2026.06)

000250

Price
₩157,000
Change
+1.03%
Market cap
₩3.7tn
Prev. close
₩155,400
000250 SummaryCompare to Peers

More 000250 filings

5% Ownership Report — Large Holdings

08/14/26

Material matter affecting investment judgment (clinical trial plan approval)

08/05/26

Material matter affecting investment judgment (clinical trial plan applied for)

08/05/26

5% Ownership Report — Large Holdings

07/23/26

Appointment, dismissal or early departure of an independent director

06/30/26

Results of an extraordinary general meeting

06/30/26